Blood Donation and Blood Transfusion: Special Considerations for African Americans

Transfusion Medicine Reviews

Volumn 22, Issue 3, 2008, Pages 202-214

  Shaz, Beth H ^a   Zimring, James C ^a   Demmons, Derrick G ^a   Hillyer, Christopher D ^a  

^a Center for Transfusion and Cellular Therapies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ALLOIMMUNIZATION; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CYTOPENIA; DEMOGRAPHY; ERYTHROCYTE; ETHNICITY; GENOTYPE; HEMOLYSIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PATIENT CARE; PHENOTYPE;

AFRICAN AMERICANS; ANEMIA, SICKLE CELL; BLOOD DONORS; BLOOD TRANSFUSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; UNITED STATES;

EID: 45249119523     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2008.02.006     Document Type: Article

References (80)

1. Hillyer C.D., Silberstein L.E., Ness P.M., et al. Blood banking and transfusion medicine: Basic principles & practice. (ed 2) (2007), Churchill Livingstone, Philadelphia
2. Sullivan M.T., Cotten R., Read E.J., et al. Blood collection and transfusion in the United States in 2001. Transfusion 47 (2007) 385-394
3. Mathew S.M., King M.R., Glynn S.A., et al. Opinions about donating blood among those who never gave and those who stopped: A focus group assessment. Transfusion 47 (2007) 729-735
4. Riley W., Schwei M., and McCullough J. The Unites States' potential blood donor pool: Estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion 47 (2007) 1180-1188
5. Price C.L., Boyd J.H., Watkins A.R., et al. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion 46 (2006) 1388-1393
6. McCarthy M. Number of cancer deaths continues to fall in USA. Lancet 369 (2007) 263
7. Moran A., Diez Roux A.V., Jackson S.A., et al. Acculturation is associated with hypertension in a multiethnic sample. Am J Hypertens 20 (2007) 354-363
8. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 115 (2007) e69-e171
9. Brancati F.L., Kao W.H.L., Folsom A.R., et al. Incident type 2 diabetes mellitus in African American and White adults: The Atherosclerosis Risk in Communities Study. JAMA 283 (2000) 2253-2259
10. Powe N.R. To have and have not: Health and health care disparities in chronic kidney disease. Kidney Int 64 (2003) 763-772
11. Racial/ethnic disparities in diagnoses of HIV/AIDS-33 states, 2001-2005. MMWR 56 (2007) 189-193
12. Robins E.B., and Blum S. Hematologic reference values for African American children and adolescents. Am J Hematol 82 (2006) 611-614
13. McClung J.P., Marchitelli L.J., Friedl K.E., et al. Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr 25 (2006) 64-69
14. Sebok M.A., Notari E.P., Chambers L.A., et al. Seasonal temperature variation and the rate of donor deferral for low hematocrit in the American Red Cross. Transfusion 47 (2007) 890-894
15. Hoekstra T., Veldhuizen I., van Noord P.A.H., et al. Seasonal influences on hemoglobin levels and deferral rates in whole-blood and plasma donors. Transfusion 47 (2007) 895-900
16. Cristina V., and Beato M.D. Progress review: Medical product safety (2003), U.S. Department of Health and Human Services, Public Health Service, Washington, DC
17. Glynn S.A., Kleinman S.H., Schreiber G.B., et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 284 (2000) 229-235
18. America's Blood Centers, and Vanguard Comm. Blood donation among African Americans and Hispanics: Background, hypotheses, research questions. Multicultural donor recruitment and marketing plan: Phases I.1 secondary research report (2006) Chicago, Blackstone
19. Gillespie T.W., and Hillyer C.D. Blood donors and factors impacting the blood donation decision. Transfus Med Rev 16 (2002) 115-130
20. Oswalt R.M. A review of blood donor motivation and recruitment. Transfusion 17 (1977) 123-135
21. London P., and Hemphill B.M. The motivations of blood donors. Transfusion 5 (1965) 559-568
22. Wu Y., Glynn S.A., Schreiber G.B., et al. First-time blood donors: Demographic trends. Transfusion 41 (2001) 360-364
23. Wang B., Schreiber G.B., Glynn S.A., et al. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?. Transfusion 45 (2005) 1089-1096
24. Damesyn M.A., Glynn S.A., Schreiber G.B., et al. Behavioral and infectious disease risks in young blood donors: Implications for recruitment. Transfusion 43 (2003) 1596-1603
25. Schreiber G.B., Sharma U.K., Wright D.J., et al. First year donation patterns predict long-term commitment for first-time donors. Vox Sang 88 (2005) 114-121
26. Ownby H.E., Kong F., Watanabe K., et al. Analysis of donor return behavior. Transfusion 39 (1999) 1128-1135
27. Glynn S.A., Busch M.P., Schreiber G.B., et al. Effect of a national disaster on blood supply and safety. JAMA 289 (2003) 2246-2253
28. Glynn S.A., Kleinman S.H., Schreiber G.B., et al. Motivations to donate blood: Demographic comparisons. Transfusion 42 (2002) 216-225
29. Schreiber G.B., Schlumpf K.S., Glynn S.A., et al. Convenience, the bane of our existence, and other barriers to donating. Transfusion 46 (2006) 545-553
30. Popovsky M.A. Understanding the donor can correct the nation's blood imbalance. Transfusion 46 (2006) 501-502
31. Boulware L.E., Ratner L.E., Ness P.M., et al. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion 42 (2002) 669-678
32. Grossman B., Watkins A.R., Fleming F., et al. Barriers and motivators to blood and cord blood donations in young African-American Women. Am J Hematol 78 (2005) 198-202
33. Schoenborn C.A., Marsh S.L., and Hardy A.M. AIDS knowledge and attitudes for 1992. Data from the National Health Interview Survey. Adv Data 243 (1994) 1-16
34. Leibrecht B.C., Hogan J.M., Luz G.A., et al. Donor and nondonor motivations. Transfusion 16 (1976) 182-189
35. Hupfer M.E., Taylor D.W., and Letwin J.A. Understanding Canadian student motivations and beliefs about giving blood. Transfusion 45 (2005) 149-161
36. Alessandrin M. Community volunteerism and blood donation: Altruism as a lifestyle choice. Transfus Med Rev 21 (2007) 301-316
37. Saguaro Seminar: Civic Engagement in America. A project of the John F. Kennedy School of Government at Harvard University. Social Capital Community Benchmark Survey Executive Summary, 2000
38. Smith L.A., Oyeku S.O., Homer C., et al. A question of equity and quality. Pediatrics 117 (2006) 1763-1770
39. Josephson C.D., Su L.L., Hillyer K.L., et al. Transfusion in the patient with sickle cell disease: A critical review of the literature and transfusion guidelines. Transfus Med Rev 21 (2007) 118-133
40. Aygun B., Padmanabhan S., Paley C., et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 42 (2002) 37-43
41. Hillyer K.L., Hare V.W., Josephson C.D., et al. Partners for life: The transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia. Immunohematol 22 (2006) 108-111
42. AABB. Technical manual. ed 14 (2002), AABB, Bethesda
43. Sosler S.D., Jilly B.J., Saporito C., et al. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 43 (1993) 103-106
44. Vichinsky E.P., Luban N.L.C., Wright E., et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion 41 (2001) 1086-1092
45. Krailadsiri P., Gilcher R., and Seghatchian J. Leukoreduction of sickle cell trait blood: An unresolved issue. Transfus Apher Sci 24 (2001) 223-225
46. Schuetz A.N., Hillyer K.L., Roback J.D., et al. Leukoreduction filtration of blood with sickle cell trait. Transfus Med Rev 18 (2004) 168-176
47. Stroncek D.F., Rainer T., Sharon V., et al. Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration. Transfusion 42 (2002) 1466-1472
48. Stroncek D.F., Byrne K.M., Noguchi C.T., et al. Increasing hemoglobin oxygen saturation levels in sickle trait donor whole blood prevents hemoglobin S polymerization and allows effective white blood cell reduction by filtration. Transfusion 44 (2004) 1293-1299
49. Kelleher J.F., and Luban N.L. Transfusion of frozen erythrocytes from a donor with sickle trait. Transfusion 24 (1984) 167-168
50. Meryman H.T., and Hornblower M. Freezing and deglycerolizing sickle-trait red blood cells. Transfusion 16 (1976) 627-632
51. Kochman S.A. Role of the Food and Drug Administration in the use of molecular techniques in immunohematology. Transfusion 47 (2007) 3S-9S
52. Reid M.E. Overview of molecular methods in immunohematology. Transfusion 47 (2007) 10S-16S
53. Press C.E., Ivansco L.K., and Hillyer C.D. Public attitudes and perceptions about the safety of the United States blood supply: Results of a large US survey. Blood 102 (2003) 818a (abstr)
54. Ould amar A.K. Red blood cells from donors with sickle cell trait: A safety issue for transfusion?. Transfus Med 16 (2006) 248-253
55. Sarode R., and Altuntas F. Blood bank issues associated with red cell exchanges in sickle cell disease. J Clin Apher 21 (2006) 271-273
56. AABB. Standards for blood banks and transfusion services. ed 24 (2006), AABB, Bethesda, MD
57. Vichinsky E.P., Earles A., Johnson R.A., et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322 (1990) 1617-1621
58. Win N., Doughty H., Telfer P., et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 41 (2001) 323-328
59. Petz L.D., Calhoun L., Shulman I.A., et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 37 (1997) 382-392
60. Darabi K., and Dzik S. Hyperhemolysis syndrome in anemia of chronic disease. Transfusion 45 (2005) 1930-1933
61. Hendrickson J.E., Chadwick T.E., Roback J.D., et al. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 110 (2007) 2736-2743
62. Hendrickson J.E., Desmarets M., Deshpande S.S., et al. Recipient inflammation affects the frequency and magnitude of immunization to transfusion red blood cells. Transfusion 46 (2006) 1526-1536
63. Yu J., Heck S., and Yazdanbakhsh K. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol 82 (2007) 691-696
64. Okpala I. The intriguing contribution of white blood cells to sickle cell disease-A red cell disorder. Blood Rev 18 (2004) 65-73
65. Avent N.D. Large scale blood group genotyping. Transfus Clin Biol 14 (2007) 10-15
66. Lau F.Y., Wong R., Chan N.P., et al. Provision of phenotype-matched blood units: No need for pre-transfusion antibody screening. Haematologica 86 (2001) 742-748
67. Castilho L., Rios M., Bianco C., et al. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion 42 (2002) 232-238
68. National Institutes of Health, National Heart, Lung, and and Blood Institute. Management of sickle cell disease. ed 4 (2002), National Institutes of Health, Washington. http://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf NIH publication 02-2117
69. Tahhan H.R., Holbrook C.T., Braddy L.R., et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 34 (1994) 562-569
70. Afenyi-Annan A., and Bandarenko N. Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematol 22 (2006) 103-107
71. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., et al. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 104 (2004) 2263-2268
72. Anderson S.A., Menis M., O'Connell K., et al. Blood use by inpatient elderly population in the United States. Transfusion 47 (2007) 582-592
73. Lee M.T., Piomelli S., Granger S., et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): Extended follow-up and final results. Blood 108 (2006) 847-852
74. Machado R.F. Nitric oxide-based therapies in sickle cell disease: The evidence continues to mount. Crit Care Med 35 (2007) 654-655
75. Kato G.J., Gladwin M.T., and Steinberg M.H. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 21 (2007) 37-47
76. Lezcano N.E., Odo N., Kutlar A., et al. Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke 37 (2006) 1424-1426
77. Weiner D.L., Hibberd P.L., Betis P., et al. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA 289 (2003) 1136-1142
78. Machado R.F., Martyr S., Kato G.J., et al. Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol 130 (2005) 445-453
79. Pawloski J.R., and Stamler J.S. Nitric oxide in RBCs. Transfusion 42 (2002) 1603-1609
80. Dzik S. Nitric oxide: Nature's third respiratory gas. Transfusion 42 (2002) 1532-1533